CORRECTED-Valeant cuts revenue, profit forecasts

Wed Dec 16, 2015 6:32am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

(Corrects paragraph 1 to remove reference to 2016)

Dec 16 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc cut its revenue and profit forecasts for 2015.

The company, which is holding its investor day on Wednesday, said it still expected double-digit sales growth through higher volumes. (Reporting by Vidya L Nathan in Bengaluru; Editing by Sriraj Kalluvila)